UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Antibody-Drug Conjugate-Based Therapeutics: State of the Science

JNCI : Journal of the National Cancer Institute, 2019-06, Vol.111 (6), p.538-549

2019

Link zum Volltext

Verfügbarkeit prüfen

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2654-2663

2012

Link zum Volltext

Verfügbarkeit prüfen

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

The New England journal of medicine, 2011-12, Vol.365 (26), p.2473-2483

2011

Link zum Volltext

Verfügbarkeit prüfen

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells

Genes & development, 2017-02, Vol.31 (3), p.318-332

2017

Link zum Volltext

Verfügbarkeit prüfen

Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (38), p.13948-13953

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1112-1118

2017

Link zum Volltext

Verfügbarkeit prüfen

Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

Clinical cancer research, 2018-02, Vol.24 (4), p.777-783

2018

Link zum Volltext

Verfügbarkeit prüfen

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

The Journal of clinical investigation, 2018-02, Vol.128 (2), p.589-606

2018

Link zum Volltext

Verfügbarkeit prüfen

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

Journal of clinical oncology, 2008-02, Vol.26 (6), p.995-1005

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer

PloS one, 2012-01, Vol.7 (1), p.e29079

2012

Link zum Volltext

Verfügbarkeit prüfen

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis

PloS one, 2016-06, Vol.11 (6), p.e0156595-e0156595

2016

Link zum Volltext

Verfügbarkeit prüfen

Early tumor detection afforded by in vivo imaging of near-infrared II fluorescence

Biomaterials, 2017-07, Vol.134, p.202-215

2017

Link zum Volltext

Verfügbarkeit prüfen

Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer

Cancers, 2019-05, Vol.11 (5), p.668

2019

Link zum Volltext

Verfügbarkeit prüfen

Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer

Cancer cell, 2015-07, Vol.28 (1), p.7-9

2015

Link zum Volltext

Verfügbarkeit prüfen

FGF18 as a prognostic and therapeutic biomarker in ovarian cancer

The Journal of clinical investigation, 2013-10, Vol.123 (10), p.4435-4448

2013

Link zum Volltext

Verfügbarkeit prüfen

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer

Nature communications, 2017-12, Vol.8 (1), p.2166-2166, Article 2166

2017

Link zum Volltext

Verfügbarkeit prüfen

Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents

Journal of the American Chemical Society, 2017-03, Vol.139 (8), p.3033-3044

2017

Link zum Volltext

Verfügbarkeit prüfen

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Journal of clinical oncology, 2011-01, Vol.29 (1), p.69-75

2011

Link zum Volltext

Verfügbarkeit prüfen

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

The New England journal of medicine, 2008-12, Vol.359 (25), p.2641-2650

2008

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine

Clinical cancer research, 2019-03, Vol.25 (6), p.1727-1736

2019

Link zum Volltext

Verfügbarkeit prüfen

The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation

International journal of cancer, 2009-04, Vol.124 (8), p.1829-1840

2009

Link zum Volltext

Verfügbarkeit prüfen

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

Clinical cancer research, 2011-04, Vol.17 (8), p.2538-2548

2011

Link zum Volltext

Verfügbarkeit prüfen

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

Future oncology (London, England), 2018-07, Vol.14 (17), p.1669-1678

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic

Molecular cancer therapeutics, 2016-04, Vol.15 (4), p.560-573

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 521

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(469)
Mit Volltextzugriff
(495)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(521)
Japanisch
(84)

Erscheinungsjahr

n.n

Thema

Science & Technology
(329)
Life Sciences & Biomedicine
(300)
Humans
(265)
Oncology
(236)
Female
(210)
Ovarian Cancer
(99)
Tumors
(92)
Ovarian Neoplasms - Genetics
(87)
Ovarian Neoplasms - Pathology
(82)
Biological And Medical Sciences
(81)
Obstetrics & Gynecology
(80)
Middle Aged
(76)
Animals
(75)
Aged
(70)
Medical Sciences
(68)
Adult
(57)
Cell Biology
(57)
Gene Expression Regulation, Neoplastic
(50)
Gynecology. Andrology. Obstetrics
(50)
Ovarian Neoplasms - Drug Therapy
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Antibody-Drug Conjugate-Based Therapeutics: State of the Science

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells

Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study

Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis

Early tumor detection afforded by in vivo imaging of near-infrared II fluorescence

Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer

Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer

FGF18 as a prognostic and therapeutic biomarker in ovarian cancer

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer

Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine

The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic

Suchergebnisse filtern